Ven Bio Partners LLC Pharvaris N.V. Transaction History
Ven Bio Partners LLC
- $147 Million
- Q3 2025
A detailed history of Ven Bio Partners LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, Ven Bio Partners LLC holds 4,639,304 shares of PHVS stock, worth $109 Million. This represents 78.75% of its overall portfolio holdings.
Number of Shares
4,639,304
Previous 4,289,304
8.16%
Holding current value
$109 Million
Previous $75.5 Million
53.33%
% of portfolio
78.75%
Previous 79.45%
Shares
8 transactions
Others Institutions Holding PHVS
# of Institutions
82Shares Held
51MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY8.03MShares$189 Million7.09% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.78MShares$113 Million76.4% of portfolio
-
Viking Global Investors LP3.65MShares$86 Million0.26% of portfolio
-
Eqt Fund Management S.A R.L.3.42MShares$80.6 Million4.59% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.18MShares$74.9 Million25.47% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $795M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...